Immunization with these nanoparticles induced significant antigen-specific humoral (neutralizing antibodies) and cellular responses (IFN-γ and IL-4-secreting cells and NP147–155 tetramer-specific CTL responses) and conferred heterosubtypic influenza protection. The gene discussed is IFNG; the disease is influenza.